Table 1.
number of patients under ocular hypotensive treatments and systemic treatments in the whole study population.
Table 2.
Demographic characteristics of study population and results of ANOVA analysis to compare each glaucoma severity subgroups and healthy controls.
Fig 1.
Comparison of BDNF serum levels between early glaucoma patients, moderate glaucoma patients, advanced glaucoma patients and healthy controls.
BDNF = brain derived neurotrophic factor. * = p<0.05 for the post-hoc comparisons of each glaucoma severity subgroup and healthy controls.
Fig 2.
Comparison of NGF serum levels between early glaucoma patients, moderate glaucoma patients, advanced glaucoma patients and healthy controls.
NGF = nerve growth factor. * = p<0.05 for the post-hoc comparisons of each glaucoma severity subgroup and healthy controls.
Table 3.
mean, standard deviation and 95%CI for the mean of the differences between BDNF serum levels of each glaucoma subgroup and healthy controls.
Table 4.
mean, standard deviation and 95%CI for the mean of the differences between NGF serum levels of each glaucoma subgroup and healthy controls.